[HTML][HTML] International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of …

…, I Wistuba, PC Yang, D Aberle, C Brambilla… - Journal of thoracic …, 2011 - Elsevier
Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

…, P Validire, B Besse, E Brambilla, C Brambilla… - Nature …, 2012 - nature.com
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis 1 ,
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

…, P Valagussa, A Rossi, G Tancini, C Brambilla… - Breast cancer research …, 1985 - Springer
The paper reviews all adjuvant studies carried out since 1973 at the Milan Cancer Institute
in women with resectable breast cancer and positive axillary nodes. The updated results …

Combination chemotherapy as an adjuvant treatment in operable breast cancer

…, A Rossi, L Brugnatelli, C Brambilla… - … England Journal of …, 1976 - Mass Medical Soc
Prolonged cyclic combination chemotherapy with cyclophosphamide, methotrexate and
fluorouracil was evaluated as adjuvant treatment to radical mastectomy in primary breast cancer …

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

…, B Solomon, E Brambilla, C Brambilla… - Science translational …, 2010 - science.org
Lung cancer remains one of the leading causes of cancer-related death in developed countries.
Although lung adenocarcinomas with EGFR mutations or EML4-ALK fusions respond to …

American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

…, B Wallaert, CG Brambilla… - … of respiratory and …, 2002 - mayoclinic.elsevierpure.com
Despite the considerable progress in the classification of the idiopathic interstitial pneumonias
(IIPs), the lack of an international standard has resulted in variable and confusing …

[HTML][HTML] Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer—the results of 20 years of follow-up

…, A Moliterni, M Zambetti, C Brambilla - … England Journal of …, 1995 - Mass Medical Soc
Background Adjuvant combination chemotherapy with cyclophosphamide, methotrexate,
and fluorouracil was administered after radical mastectomy for primary breast cancer with …

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

G Bonadonna, U Veronesi, C Brambilla… - JNCI: Journal of the …, 1990 - academic.oup.com
In 165 women with breast cancer who were candidates for mastectomy because the largest
diameter of the tumor was 3 cm or more, we administered primary chemotherapy in the …

Early detection of lung cancer: role of biomarkers

C Brambilla, F Fievet, M Jeanmart… - European …, 2003 - Eur Respiratory Soc
Brambilla E, Gazzeri S. P53 pathway and lung cancer In: Brambilla E, Brambilla C, editors.
Fundamental biology and clinical managementM Dekker New-York, Basel, 1998; pp. 173–…

Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

…, S Querings, S Ansén, E Brambilla, C Brambilla… - Cancer discovery, 2011 - AACR
Although genomically targeted therapies have improved outcomes for patients with lung
adenocarcinoma, little is known about the genomic alterations that drive squamous cell cancer (…